Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2016 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.
Leuk Lymphoma. 2023 May;64(5):913-926. doi: 10.1080/10428194.2023.2216327. Epub 2023 May 31.
Leuk Lymphoma. 2023.
PMID: 37255002
Clinical Trial.
Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages.
Suárez-Cabrera A, Fiallo-Suárez DV, Stuckey R, Uroz-de la Iglesia ML, Florido Y, Lemes-Castellano A, Perera-Álvarez MÁ, Luzardo-Henríquez H, de la Nuez H, Fernández-Caldas P, de la Iglesia S, Gómez-Casares MT, Bilbao-Sieyro C.
Suárez-Cabrera A, et al.
Diagnostics (Basel). 2022 Jul 25;12(8):1802. doi: 10.3390/diagnostics12081802.
Diagnostics (Basel). 2022.
PMID: 35892513
Free PMC article.
Item in Clipboard
Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents.
De la Iglesia Iñigo S, López-Jorge CE, Gómez-Casares MT, Lemes Castellano A, Martín Cabrera P, López Brito J, Suárez Cabrera A, Molero Labarta T.
De la Iglesia Iñigo S, et al. Among authors: suarez cabrera a.
Leuk Res. 2009 Jun;33(6):810-6. doi: 10.1016/j.leukres.2008.09.029. Epub 2008 Nov 17.
Leuk Res. 2009.
PMID: 19010543
Item in Clipboard
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF; Spanish Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Groups.
Paiva B, et al.
Blood. 2016 Apr 14;127(15):1896-906. doi: 10.1182/blood-2015-08-665679. Epub 2016 Jan 11.
Blood. 2016.
PMID: 26755711
Free article.
Clinical Trial.
Item in Clipboard
Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin.
de la Nuez Melián H, Luzardo Henríquez H, Suárez Cabrera A, Stuckey R, Gómez-Casares MT.
de la Nuez Melián H, et al. Among authors: suarez cabrera a.
Leuk Lymphoma. 2024 Jun 3:1-3. doi: 10.1080/10428194.2024.2360520. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 38829355
No abstract available.
Item in Clipboard
Cite
Cite